Austrian Real-world Experience With Standard of Care Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle-Cell LymphomaStefan Koeck, Thomas Melchardt, Christoph Grabmer et al.|Transplantation and Cellular Therapy|2026Cited by 1